Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reducing Acute Upper Gastrointestinal Side-Effects of Thoracic Irradiation
NCT05659576Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Dec 2022
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sucralfate in radiation esophagitis, sponsored by Memorial Sloan Kettering Cancer Center. Started Dec 2022; status: completed.
02
Drugs
sucralfate
03
Conditions
radiation esophagitis
Beyond the preview
Go deeper on NCT05659576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05659576.